February 7, 2020—The Senate Health Policy & Human Services Committee held a second hearing on Senate Bill 612 this week, in follow up to the Jan. 30 hearing.
Health Can't Wait proponents of the bill shared data and real life stories of how the current prior authorization requirements and step therapy are delaying care, which leads to needless suffering and poor outcomes. Their testimony underscores why transparency, timeliness, and clinical validity must be added to the prior authorization process.
MCG Health—a third party that provides evidence-based standards and tools to guide insurers in making prior authorization determinations—and Michigan Association of Health Plans offered testimony in opposition to SB 612. They contend that prior authorization ensures patients receive quality care at an affordable price, costs are contained, waste and efficiencies are minimized, and patient safety is protected.